Avalon GloboCare Corp. (ALBT)
NASDAQ: ALBT
· Real-Time Price · USD
2.31
-0.07 (-2.94%)
At close: Oct 01, 2025, 3:59 PM
2.35
1.73%
Pre-market: Oct 02, 2025, 08:23 AM EDT
-2.94% (1D)
| Bid | 2.3 |
| Market Cap | 8.78M |
| Revenue (ttm) | 1.39M |
| Net Income (ttm) | -20.34M |
| EPS (ttm) | -11.85 |
| PE Ratio (ttm) | -0.19 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 2.43 |
| Volume | 39,187 |
| Avg. Volume (20D) | 687,866 |
| Open | 2.38 |
| Previous Close | 2.38 |
| Day's Range | 2.30 - 2.38 |
| 52-Week Range | 1.87 - 11.66 |
| Beta | 0.01 |
| Ex-Dividend Date | n/a |
About ALBT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALBT
Website n/a
2 months ago
+30.84%
Avalon GloboCare shares are trading higher after t...
Unlock content with
Pro Subscription
2 months ago
+6.27%
Avalon GloboCare shares are trading higher after the company announced it received a patent from the Hong Kong Intellectual Property Department for its CAR-T and CAR-Natural Killer cell technology.
